Two articles were published about Curis Inc.'s (Nasdaq: CRIS) experimental cancer treatment GDC-0449 sending the stock price up 31 cents to close at $2.41.
Two Articles Written About Curis' Cancer Treatment
September 03, 2009 at 17:12 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.